Conversely, CDK1 mRNA stability was increased in breast cancer cells after CD2BP2‐DT overexpression, but this increase was inhibited when YBX1 was knocked down during CD2BP2‐DT overexpression (Figure 4J; Figure S4L, Supporting Information). Here, CD2BP2 is linked to breast carcinoma.